BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16715135)

  • 1. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
    James SR; Link PA; Karpf AR
    Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XIST repression in the absence of DNMT1 and DNMT3B.
    Vasques LR; Stabellini R; Xue F; Tian XC; Soukoyan M; Pereira LV
    DNA Res; 2005; 12(5):373-8. PubMed ID: 16769694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation.
    Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH
    Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
    Loriot A; De Plaen E; Boon T; De Smet C
    J Biol Chem; 2006 Apr; 281(15):10118-26. PubMed ID: 16497664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
    Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
    Przybylski M; Kozłowska A; Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2010 Apr; 64(4):254-8. PubMed ID: 19932585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.
    Xue G; Ren Z; Chen Y; Zhu J; Du Y; Pan D; Li X; Hu B
    Cancer Lett; 2015 May; 361(1):121-7. PubMed ID: 25749421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
    Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
    Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
    Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
    Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.
    Woloszynska-Read A; James SR; Song C; Jin B; Odunsi K; Karpf AR
    Cancer Immun; 2010 Jul; 10():6. PubMed ID: 20649179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription.
    Majumder S; Ghoshal K; Datta J; Smith DS; Bai S; Jacob ST
    J Biol Chem; 2006 Aug; 281(31):22062-22072a. PubMed ID: 16735507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.
    Sun L; Huang L; Nguyen P; Bisht KS; Bar-Sela G; Ho AS; Bradbury CM; Yu W; Cui H; Lee S; Trepel JB; Feinberg AP; Gius D
    Cancer Res; 2008 Apr; 68(8):2726-35. PubMed ID: 18413740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival.
    Egger G; Jeong S; Escobar SG; Cortez CC; Li TW; Saito Y; Yoo CB; Jones PA; Liang G
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14080-5. PubMed ID: 16963560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
    Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation, mRNA expression of goat tumor‑associated genes and mRNA expression of DNA methyltransferase in enzootic nasal tumors.
    Quan Z; Ye N; Hao Z; Wen C; Liao H; Zhang M; Luo L; Cao S; Wen X; Wu R; Yan Q
    Mol Med Rep; 2015 Oct; 12(4):6275-85. PubMed ID: 26252527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma.
    Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
    Int J Cancer; 2003 May; 104(5):568-78. PubMed ID: 12594811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.